Literature DB >> 24158730

Hsa-miR-132 regulates apoptosis in non-small cell lung cancer independent of acetylcholinesterase.

Bo Zhang1, Lu Lu, Xuejin Zhang, Weiyuan Ye, Jun Wu, Qiliang Xi, Xuejun Zhang.   

Abstract

MiR-132 is enriched in the central nerve system and is thought to be involved in neuronal development, maturation and function, and to be associated with several neurological disorders including Alzheimer's disease. In addition to its documented neuronal functions, an emerging role for miR-132 in tumorigenesis has been suggested. Recently, hsa-miR-132 was shown to be modulated in different tumor types. However, its role in non-small cell lung cancer (NSCLC) remains unclear. Here, we show that hsa-miR-132 can initiate apoptosis in NSCLC cells to dramatically attenuate tumor formation in nude mice independent of its effect on the proliferation/apoptosis-associated gene, acetylcholinesterase (AChE). Interestingly, hsa-miR-132 has no pro-apoptotic effect in normal pulmonary trachea epithelium. Taken together, these results suggest that hsa-miR-132 represses NSCLC growth by inducing apoptosis independent of AChE.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24158730     DOI: 10.1007/s12031-013-0136-z

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  43 in total

Review 1.  The morphology of apoptosis.

Authors:  G Häcker
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

2.  Acetylcholinesterase, a key prognostic predictor for hepatocellular carcinoma, suppresses cell growth and induces chemosensitization.

Authors:  Yingjun Zhao; Xiaoying Wang; Tao Wang; Xin Hu; Xin Hui; Mingxia Yan; Qiang Gao; Taoyang Chen; Jinjun Li; Ming Yao; Dafang Wan; Jianren Gu; Jia Fan; Xianghuo He
Journal:  Hepatology       Date:  2011-01-03       Impact factor: 17.425

3.  Adjuvant therapy for non-small cell lung cancer.

Authors:  Letícia Barbosa França; Márcia Aparecida Oliveira; Isabele Ávila Small; Mauro Zukin; Luiz Henrique de Lima Araújo
Journal:  J Bras Pneumol       Date:  2011 May-Jun       Impact factor: 2.624

Review 4.  Adjuvant therapy in non-small cell lung cancer: current and future directions.

Authors:  Randeep Sangha; Julie Price; Charles A Butts
Journal:  Oncologist       Date:  2010-08-03

Review 5.  The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group.

Authors:  Erik Thunnissen; Keith M Kerr; Felix J F Herth; Sylvie Lantuejoul; Mauro Papotti; Robert C Rintoul; Giulio Rossi; Birgit G Skov; Birgit Weynand; Lukas Bubendorf; Grünberg Katrien; Leif Johansson; Fernando López-Ríos; Vincent Ninane; Włodzimierz Olszewski; Helmut Popper; Sauleda Jaume; Philipp Schnabel; Luc Thiberville; Florian Laenger
Journal:  Lung Cancer       Date:  2011-12-03       Impact factor: 5.705

6.  The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma.

Authors:  Nelson G Ordóñez
Journal:  Am J Surg Pathol       Date:  2003-08       Impact factor: 6.394

7.  CREB regulates AChE-R-induced proliferation of human glioblastoma cells.

Authors:  Chava Perry; Ella H Sklan; Hermona Soreq
Journal:  Neoplasia       Date:  2004 May-Jun       Impact factor: 5.715

8.  Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology.

Authors:  Amit Berson; Marlen Knobloch; Mor Hanan; Sophia Diamant; Michal Sharoni; Daniel Schuppli; Brian C Geyer; Rivka Ravid; Tsafrir S Mor; Roger M Nitsch; Hermona Soreq
Journal:  Brain       Date:  2007-12-03       Impact factor: 13.501

Review 9.  Role of apoptosis in disease.

Authors:  Bartolo Favaloro; Nerino Allocati; Vincenzo Graziano; Carmine Di Ilio; Vincenzo De Laurenzi
Journal:  Aging (Albany NY)       Date:  2012-05       Impact factor: 5.682

10.  Real-time quantification of microRNAs by stem-loop RT-PCR.

Authors:  Caifu Chen; Dana A Ridzon; Adam J Broomer; Zhaohui Zhou; Danny H Lee; Julie T Nguyen; Maura Barbisin; Nan Lan Xu; Vikram R Mahuvakar; Mark R Andersen; Kai Qin Lao; Kenneth J Livak; Karl J Guegler
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

View more
  20 in total

1.  Journal of molecular neuroscience: impacting our brains.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2014-11       Impact factor: 3.444

2.  miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2.

Authors:  Yong-Bin Zheng; Hai-Ping Luo; Qiang Shi; Zhi-Nan Hao; Yu Ding; Qiu-Shuang Wang; Sheng-Bo Li; Gao-Chun Xiao; Shi-Lun Tong
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

3.  miR-132 suppresses the migration and invasion of lung cancer cells by blocking USP9X-induced epithelial-mesenchymal transition.

Authors:  Huihui Guo; Xilin Zhang; Qiuqiang Chen; Ying Bao; Chaohui Dong; Xiang Wang
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

4.  MicroRNA-132 suppresses cell proliferation in human breast cancer by directly targeting FOXA1.

Authors:  Dan Wang; Jin Ren; Hui Ren; Jin-Ling Fu; Dan Yu
Journal:  Acta Pharmacol Sin       Date:  2017-08-17       Impact factor: 6.150

5.  Preliminary evaluation of circulating microRNAs as potential biomarkers in paracoccidioidomycosis.

Authors:  Junya De Lacorte Singulani; Julhiany De Fátima Da Silva; Fernanda Patricia Gullo; Marina Célia Costa; Ana Marisa Fusco-Almeida; Francisco Javier Enguita; Maria José Soares Mendes-Giannini
Journal:  Biomed Rep       Date:  2017-01-26

6.  Expression profiles of miR-196, miR-132, miR-146a, and miR-134 in human colorectal cancer tissues in accordance with their clinical significance : Comparison regarding KRAS mutation.

Authors:  Mahafarin Maralani; Dariush Shanehbandi; Milad Asadi; Shahriar Hashemzadeh; Khalil Hajiasgharzadeh; Hossein Mashhadi Abdolahi; Behzad Baradaran; Marc Peeters
Journal:  Wien Klin Wochenschr       Date:  2021-08-31       Impact factor: 1.704

7.  MicroRNA-132 targets PEA-15 and suppresses the progression of astrocytoma in vitro.

Authors:  Fei Geng; Jian-Lin Wu; Gui-Feng Lu; Zhi-Ping Liang; Zhuo-Li Duan; Xi Gu
Journal:  J Neurooncol       Date:  2016-06-13       Impact factor: 4.130

8.  The protective role of tacrine and donepezil in the retina of acetylcholinesterase knockout mice.

Authors:  Yun-Min Yi; Li Cai; Yi Shao; Man Xu; Jing-Lin Yi
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

9.  miR-132 targeting E2F5 suppresses cell proliferation, invasion, migration in ovarian cancer cells.

Authors:  Hang Tian; Lei Hou; Yu-Mei Xiong; Jun-Xiang Huang; Wen-Hua Zhang; Yong-Ying Pan; Xing-Rong Song
Journal:  Am J Transl Res       Date:  2016-03-15       Impact factor: 4.060

10.  Upregulation of miR-132 expression in glioma and its clinical significance.

Authors:  Qiang Liu; Fan Liao; Hao Wu; Tao Cai; Liang Yang; Zhi-Fei Wang; Ran Zou
Journal:  Tumour Biol       Date:  2014-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.